These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10563108)

  • 21. [Tested and new chemotherapy in infectious diseases].
    Hoigné R; Keller MF
    Schweiz Med Wochenschr; 1972 Jul; 102(27):933-40. PubMed ID: 4558901
    [No Abstract]   [Full Text] [Related]  

  • 22. [The most comprehensive survey of the treatment of infections in primary health care. Prescription of antibiotics is not always according to the guidelines].
    Mölstad S
    Lakartidningen; 2003 Jan; 100(5):318-21. PubMed ID: 12607377
    [No Abstract]   [Full Text] [Related]  

  • 23. Randomized, double-blind, comparative study of levofloxacin and ofloxacin in the treatment of complicated urinary tract infections.
    Peng MY
    J Microbiol Immunol Infect; 1999 Mar; 32(1):33-9. PubMed ID: 11561568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community-acquired bacterial respiratory tract infections.
    Brunton S; Carmichael B; Fitzgerald M; Liu H; Varon J; Weiland D
    J Fam Pract; 2005 Mar; 54(3):255-62. PubMed ID: 15755379
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapy with trimethoprim-sulfonamide. Clinical results].
    Garrod LP
    Recenti Prog Med; 1971 Nov; 51(5):471-88. PubMed ID: 5172399
    [No Abstract]   [Full Text] [Related]  

  • 26. [Observational study investigating the use of levofloxacin in ICU patients].
    Alvarez-Lerma F; Palomar M; Olaechea P; León C; Sánchez M; Bermejo B;
    Enferm Infecc Microbiol Clin; 2004 Apr; 22(4):220-6. PubMed ID: 15056438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ten-year experience with the use of ofloxacin (Tarivid*). New treatment regimens].
    Navashin SM; Navashin PS; Smirnova LB
    Antibiot Khimioter; 1996; 41(9):99-103. PubMed ID: 9005800
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effectiveness of levofloxacin (Tavanik, "Aventis Pharma") in the treatment of complicated infections of the urogenital organs].
    Derevianko II; Lavrinova LN; Kudriashova EE
    Urologiia; 2003; (1):31-4. PubMed ID: 12621964
    [No Abstract]   [Full Text] [Related]  

  • 29. Infections in the elderly: current concepts in management.
    Madhavan T
    Compr Ther; 1994; 20(8):465-70. PubMed ID: 7956104
    [No Abstract]   [Full Text] [Related]  

  • 30. Newer fluoroquinolones and the management of respiratory tract infections.
    Karchmer AW
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S15. PubMed ID: 10984322
    [No Abstract]   [Full Text] [Related]  

  • 31. New fluoroquinolone antibiotics.
    Drug Ther Bull; 1999 Jan; 37(1):6-8. PubMed ID: 10562769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Levofloxacin in the treatment of respiratory infections].
    Iakovlev SV; Iakovlev VP
    Antibiot Khimioter; 2002; 47(8):32-42. PubMed ID: 12515095
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fluoroquinolone. 2. Pharmacokinetics and clinical use].
    Kemmerich B; Stahlmann R; Lode H
    Dtsch Med Wochenschr; 1988 Apr; 113(17):693-5. PubMed ID: 3282865
    [No Abstract]   [Full Text] [Related]  

  • 35. Respiratory fluoroquinolones: differences in the details.
    Mandell LA; Iannini PB; Tillotson GS
    Clin Infect Dis; 2004 May; 38(9):1331-2; author reply 1332-3. PubMed ID: 15127351
    [No Abstract]   [Full Text] [Related]  

  • 36. Re: treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
    Olapade-Olaopa EO; Adebayo SA
    J Urol; 2006 Jun; 175(6):2365-6; author reply 2366. PubMed ID: 16697876
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of antibiotics in the treatment of community-acquired infections of the lower respiratory tract in the elderly].
    Sanguinetti CM
    Int J Clin Pract Suppl; 2000 Jan; (109):8-10. PubMed ID: 10765555
    [No Abstract]   [Full Text] [Related]  

  • 38. Activity of levofloxacin, ofloxacin, D-ofloxacin and ciprofloxacin against systemic and respiratory tract infections in laboratory animals.
    Klesel N; Geweniger KH; Koletzki P; Isert D; Limbert M; Markus A; Riess G; Schramm H; Seibert G; Iyer P
    Drugs; 1995; 49 Suppl 2():211-4. PubMed ID: 8549307
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical evaluation of levofloxacin 200 mg 3 times daily in the treatment of bacterial lower respiratory tract infections.
    Kawai T
    Drugs; 1995; 49 Suppl 2():416-7. PubMed ID: 8549383
    [No Abstract]   [Full Text] [Related]  

  • 40. New generations of quinolones: with particular attention to levofloxacin.
    Ambrose PG; Owens RC; Quintiliani R; Nightingale CH
    Conn Med; 1997 May; 61(5):269-72. PubMed ID: 9197076
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.